Embracing Opportunities from Potential Technologies and Partnerships
29 - 30 October 2008, JW Marriott Hotel Seoul, South Korea
Event Agenda
Key Conference Topics
Strategies for developments in the drug delivery business
Drug delivery compulsions: Going forward
Demands of biotech companies for new and innovative delivery technology in today’s market
Scouting, sourcing and selection of drug delivery system
Regulatory Reform: The key to innovations in drug delivery
Commercialization of drug delivery R&D: Manufacturing & scale up issues
Drug Delivery and individualized therapy: Towards flexibility in development and manufacturing
Panel Discussion – Pharmaceutical partnership as the key to success in the drug delivery market
Novel developments in protein drug delivery
Reversible lipidization of protein and peptide drugs: A study of lipidized human interferon-alpha
Controlled DDS for therapeutic biomolecules: Hyaluronate-based sustained release system
New transdermal delivery technologies: Meeting challenges and providing product solutions
Conjugation and Delivery Technologies for Biopharmaceuticals: Applications to Nucleotide, Peptide, and Protein Therapeutics
Trends & challenges in drug delivery
Trends in Oral Drug Delivery Systems
Case study – Beyond Liposome: An Asian Company going Global
New technological application for drug delivery
Development of Sustained Drug Delivery Technology
Ceramic particles for Drug Delivery
Silicone Drug Delivery Devices: Control and Release
Panel discussion – Eye on the future: Strategies in developing innovative drug delivery technologies
New scientific frontiers in drug delivery research
A new versatile and approvable formulation strategy applicable to a wide range of therapeutics: Remarkable results obtained by sub-lingual administration of GLP-1 peptides
Cancer gene therapy for malignant brain tumor with adenoviral delivery of pro-apoptotic TRAIL gene
Enhanced transduction efficiency of recombinant adenoviruses into cancer & stem cells by oligomeric cell-permeable peptide: An innovative tool for cell-based gene therapy